title: [Monitoring the Secondary Prevention of Coronary Artery Disease in Europe and Russia: Results of the Russian Part of the International Multicenter Study EUROASPIRE IV].
abstract: The results of the Russian part of the EUROASPIRE IV study show that we have a large room for improvement of traditional risk factors management in CAD patients hospitalized for acute myocardial infarction, acute coronary syndromes, PCI or CABG (at average in 1.7 years of follow-up after index events). It is also true for other European countries, although certain differences exist between Russian and whole study population. In some respects, the results of secondary prevention in Russian patients were even more successful: e.g. effective blood pressure control was achieved in 73.4% of our patients taking antihypertensive drugs vs 53.5% in whole study population. In contrast, smoking was more prevalent among Russian patients (22.2% vs 15.0% in other countries). Obviously, it was related to lower frequency of smoking cessation support offered to our patients: only 1.1% were referred to a smoking cessation program, 3.2% were prescribed nicotine replacement therapy, none were prescribed varenicline (vs 18.6, 22.9, 6.2%, respectively, in whole study population). The Russian cohort had the highest rate of overweight and obesity compared to other European countries (93.1 vs 82.1% in whole study population). 74.9% our patients received lipid lowering drugs (vs 86.6% in Europe), although the LDL-C goal was achieved only in 15.9% of our patients taking lipid lowering drugs (vs 21.1% in whole study population).
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: N V
authors.initials: NV
authors.lastname: Pogosova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: R G
authors.initials: RG
authors.lastname: Oganov
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: S A
authors.initials: SA
authors.lastname: Boytsov
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: A K
authors.initials: AK
authors.lastname: Ausheva
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: O J
authors.initials: OJ
authors.lastname: Sokolova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: A A
authors.initials: AA
authors.lastname: Kursakov
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: Y M
authors.initials: YM
authors.lastname: Pozdnyakov
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: Ma O
authors.initials: MO
authors.lastname: Salbieva
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: I N
authors.initials: IN
authors.lastname: Lelchuk
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: T A
authors.initials: TA
authors.lastname: Gusarova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: Mn V
authors.initials: MV
authors.lastname: Gomyranova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: N A
authors.initials: NA
authors.lastname: Skazin
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: N A
authors.initials: NA
authors.lastname: Yeliseeva
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: E B
authors.initials: EB
authors.lastname: Akhmedova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: K K
authors.initials: KK
authors.lastname: Bedeynikova
authors.affiliation: 1National Research Center for Preventive Medicine, Moscow, Russia; 2City clinical hospital 36, Moscow, Russia.
authors.forename: M N
authors.initials: MN
authors.lastname: Kovrigina
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003324:Coronary Artery Disease / Q000453:epidemiology / Q000517:prevention & control*; D005060:Europe; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009765:Obesity; D062645:Percutaneous Coronary Intervention; D012307:Risk Factors; D012426:Russia; D055502:Secondary Prevention; D012907:Smoking; D016540:Smoking Cessation
chemical_list: D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents